Michael Aberman

Michael Aberman

Fundador en Xenimmune Therapeutics, Inc. .

53 años
Health Technology
Consumer Services
Finance

Perfil

Dr. Michael S.
Aberman
is a General Partner at Regeneron Ventures and a Chief Executive Officer & Director at Xenimmune Therapeutics, Inc. He is on the Board of Directors at Halomine, Inc. and Xenimmune Therapeutics, Inc. Dr. Aberman was previously employed as a Senior VP-Strategy & Investor Relations by Regeneron Pharmaceuticals, Inc., a Research Analyst by Credit Suisse Securities (USA) LLC (Broker), a Research Associate by Morgan Stanley & Co., Inc., a Director-Business Development by Antigenics, Inc. (Delaware), and a President & Chief Executive Officer by Quentis Therapeutics, Inc. He received his undergraduate degree from Cornell University, an MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from the University of Toronto.

Cargos activos de Michael Aberman

EmpresasCargoInicio
Director/Miembro de la Junta 03/11/2021
Fundador -
Todos los cargos activos de Michael Aberman

Antiguos cargos conocidos de Michael Aberman.

EmpresasCargoFin
Analyst-Equity 21/03/2010
Analyst-Equity 31/05/2006
AGENUS INC. Corporate Officer/Principal 01/03/2004
Director Ejecutivo -
REGENERON PHARMACEUTICALS, INC. Contacto de Relaciones con Inversores -
Ver el detalle de la experiencia de Michael Aberman.

Formación de Michael Aberman.

University of Toronto Doctorate Degree
Cornell University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Aberman.

Relaciones

100 +

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
REGENERON PHARMACEUTICALS, INC.

Health Technology

AGENUS INC.

Health Technology

Empresas privadas5

Finance

Finance

Health Technology

Process Industries

Health Technology

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA